Cassava Sciences Inc.
6801 N. Capital of Texas Highway Building 1
Austin
TX
78731
United States
Website: https://www.cassavasciences.com/
285 articles about Cassava Sciences Inc.
-
Pain Therapeutics Announces Second Quarter 2007 Financial Results
8/9/2007
-
Pain Therapeutics to Present At the Goldman, Sachs & Co. Healthcare Conference
6/6/2007
-
Pain Therapeutics to Present at Two Upcoming Investor Conferences
5/22/2007
-
Pain Therapeutics Announces First Quarter 2007 Financial Results
5/2/2007
-
Pain Therapeutics Announces $20 Million Stock Buyback Plan
3/29/2007
-
The Day In Review: Eisai Inc. Buys Morphotek Inc. For $325 Million
3/22/2007
-
Pain Therapeutics Licenses Biotechnology To Treat Rare Disorder
3/22/2007
-
Pain Therapeutics Cleared to Initiate Phase I Study in Metastatic Melanoma
3/20/2007
-
Chromos Molecular Systems Inc. And Pain Therapeutics Sign Cell Line Engineering Agreement
3/20/2007
-
Pain Therapeutics to Participate at Oppenheimer's Pain Management Conference
2/27/2007
-
Pain Therapeutics Announces Fourth Quarter And Year-End 2006 Financial Results
2/5/2007
-
Pain Therapeutics Initiates Phase III Study With Oxytrex(TM)
12/13/2006
-
Pain Therapeutics Announces Positive Phase I Study Results With PTI-202
11/29/2006
-
Pain Therapeutics Announces New Clinical Opportunity In Metastatic Melanoma
11/9/2006
-
Pain Therapeutics Announces Third Quarter 2006 Financial Results
10/25/2006
-
Pain Therapeutics Release: Oxytrex(TM) Mechanism Of Action Further Elucidated
10/17/2006
-
Pain Therapeutics To Present At The UBS Warburg Global Life Sciences Conference
9/20/2006
-
Pain Therapeutics Announces Second Quarter 2006 Financial Results
8/9/2006
-
The Day In Review: Pozen, Inc. Inks Pain Deal With AstraZeneca PLC
8/2/2006
-
Pain Therapeutics And King Pharmaceuticals®, Inc. Initiate Clinical Program Of A Second Abuse-Resistant Painkiller; Triggers $5 Million Milestone Payment
8/2/2006